Azbil Telstar, which operates in over 100 countries and has 7 production plants, 7 technology centers and 13 consulting and engineering services centers all over the world, opens its new center in Bangladesh.
The globally reputed company will run its activities in Bangladesh as a joint venture company of Japan-Spain-Bangladesh under the banner of “Azbil Telstar Bangladesh Limited (ATBD).
Health minister Mohammed Nasim formally inaugurated the new center of Azbil Telstar yesterday in a city hotel. Speaking as chief guest, Mohammed Nasim has assured of extending all-out support from the government for ensuring further growth and development of the pharmaceutical industries in Bangladesh.
“Beside RMG sector, the pharmaceutical industry is also growing fast as it has been contributing a lot in the national economy.”
Nasim has urged the pharmaceutical company owners to remain alert against the production of fake and substandard drugs as a section of dishonest people has been trying to tarnish the goodwill of the pharmaceuticals sector by manufacturing such fake drugs.
The opening of Telstar’s new center, which is specifically focused on reinforcing a professional and specialized service in the Asia-Specific region’s pharmaceuticals market, is in response to a requirement to promote growth in a region where the company has been active over the past 10 years.
In Bangladesh Azbil Telstar had previous experience of working with Square, Beximco, JMI, and Beckon, SK&F and other few pharmaceuticals company. They had earlier established different high tech solutions in design, engineering, construction and manufacturing process with automation technologies of these companies.
Through the opening of the new center, the Telstar brand is now represented in this region by three specialised production plants and engineering centers in China, Bangladesh and India, to provide specialised engineering and construction projects , equipment design and manufacture and consultancy services for the life sciences sector.
The inaugural ceremony was attended, among others, by Abdul Muktadir, secretary general of Bangladesh Association of Pharmaceuticals Industry (BAPI), Tapan Chowdhury, Managing Director of Square Pharmaceuticals, Major General Md. Jahangir hossain Mollick, Director General (DG) of Directorate General of Drug administration (DGDA), Luis Tajeda, ambassador of Spain, Shiro Sadoshima, ambassador of Japan, S.A.Khan, Managing Director of Saka International limited, Ton Capella, chairman of Azbil Telstars, Rafael Beaus, Managing director of Azbil Telstar Bangladesh and Hedeya Saito, general manager of life science engineering department of Azbil Corporation were the speakers.
